BNP PARIBAS FINANCIAL MARKETS - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2023$3,012,820
-26.6%
3,106,000
-22.4%
0.00%
-33.3%
Q1 2023$4,103,920
-67.0%
4,000,000
-65.9%
0.01%
-68.4%
Q4 2022$12,454,356
-100.0%
11,735,000
-8.0%
0.02%
-59.6%
Q3 2022$29,471,181,000
+120.6%
12,760,835
-5.4%
0.05%
+123.8%
Q2 2022$13,360,050,000
+91.0%
13,495,000
+92.8%
0.02%
+133.3%
Q1 2022$6,996,500,000
-10.3%
7,000,000
-6.2%
0.01%
-18.2%
Q4 2021$7,799,130,000
+119.3%
7,459,000
+114.6%
0.01%
+120.0%
Q3 2021$3,555,585,000
+46.2%
3,475,000
+48.1%
0.01%
+66.7%
Q2 2021$2,432,196,000
-63.7%
2,347,000
-64.6%
0.00%
-70.0%
Q1 2021$6,706,873,000
+444.9%
6,628,000
+477.9%
0.01%
+400.0%
Q4 2020$1,230,834,000
-75.1%
1,147,000
-75.6%
0.00%
-71.4%
Q3 2020$4,938,241,000
+130.1%
4,706,000
+129.8%
0.01%
+75.0%
Q1 2020$2,146,160,000
+267.9%
2,048,000
+264.4%
0.00%
+300.0%
Q2 2019$583,429,000
-73.9%
562,000
-76.4%
0.00%
-75.0%
Q1 2018$2,234,225,000
-5.8%
2,380,0000.0%0.00%0.0%
Q4 2017$2,371,075,0002,380,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
SHENKMAN CAPITAL MANAGEMENT INC 30,138,000$29,510,0003.72%
PFM Health Sciences, LP 45,910,000$46,002,0001.72%
Cheyne Capital Management (UK) LLP 2,320,000$2,330,0001.47%
ADVENT CAPITAL MANAGEMENT /DE/ 41,077,000$41,277,0000.66%
SSI INVESTMENT MANAGEMENT LLC 9,071,000$9,068,0000.50%
PALISADE CAPITAL MANAGEMENT, LP 14,548,000$14,612,0000.34%
RWC Asset Management LLP 7,500,000$7,552,0000.21%
KBC Group NV 400,000$40,316,0000.15%
PROSPECTOR PARTNERS LLC 1,000,000$1,000,0000.12%
MACKAY SHIELDS LLC 11,822,000$11,816,0000.10%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders